| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |